Dual Sympathetic Blocks for Patients Experiencing Sympathetically-Mediated Symptoms From Long COVID

NCT05638620 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Post Acute COVID-19 Syndrome
Long COVID
Long Covid19
COVID-19 Recurrent
Post-Acute COVID-19
Post-Acute COVID-19 Infection
SARS-CoV2 Infection
Post Acute Sequelae of COVID-19
Dysautonomia
Dysautonomia Like Disorder
Dysautonomia Orthostatic Hypotension Syndrome
Post COVID-19 Condition
Post-COVID Syndrome
Post COVID-19 Condition, Unspecified
Post-COVID-19 Syndrome

Interventions

DRUG: stellate ganglion block with 0.5% bupivacaine

Sponsor

Jonathann Kuo, MD